SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
Top 10 Most Recent Blog Posts
10 Best Performing Stocks: May 7, 2024
Category: Stocks Total Views: 50By : Editor Updated: 05-07-2024
Stock Market Performance and Economic Updates: May 7, 2024
Category: Markets Total Views: 57By : Editor Updated: 05-07-2024
The Future of E-commerce: Strategies for Success in 2024
Category: Business Total Views: 44By : Editor Updated: 05-07-2024
Two Harbors Investment Corp. (TWO): Stock Analysis May 7, 2024
Category: Stocks Total Views: 101By : Editor Updated: 05-07-2024
10 High-Yielding Small-Cap Stocks Under $15 in 2024
Category: Stocks Total Views: 93By : Editor Updated: 05-07-2024
Is a Stock Market Crash Looming in 2024? An In-Depth Analysis
Category: Markets Total Views: 97By : Editor Updated: 05-07-2024
5 Best Performing Stocks Under $10 as of May 7, 2024
Category: Stocks Total Views: 117By : Editor Updated: 05-07-2024
Best Stock Trading Tips for May 2024: Navigating the Market with Confidence
Category: Stocks Total Views: 102By : Editor Updated: 05-07-2024
Top 10 Performing Stocks: Analysis of May 6, 2024
Category: Stocks Total Views: 178By : Editor Updated: 05-06-2024
Today's Stock Market Performance: A Detailed Recap for May 6, 2024
Category: Markets Total Views: 168By : Editor Updated: 05-06-2024